Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Enhancers in the Treatment of Schizophrenia

NCT00328276 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00328276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00328276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Enhancers in the Treatment of Schizophrenia
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
December 31, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychoses, psychotic disorders, schizophrenias, schizophrenic disorders